Inventor · disambiguated record
Adrian Wrangham Briggs
Also filed as: BRIGGS ADRIAN · BRIGGS ADRIAN WRANGHAM
14 granted patents·24 pending applications·42 citations·filing 2014–2024
89Inventor score
Top patents by PatentIndex Score
38 records- 0194US10392614B2Methods of single-cell barcoding and sequencingABVITRO LLC·Filed 2017·Granted Aug 27, 2019·8 cites·19 claims
- 0294US10393743B2Methods of selecting T cell receptors using affinity oligonucleotide conjugatesABVITRO LLC·Filed 2017·Granted Aug 27, 2019·10 cites·31 claims
- 0393US10876107B2Single cell bar-coding for antibody discoveryABVITRO LLC·Filed 2018·Granted Dec 29, 2020·8 cites·13 claims
- 0491US10119134B2Single cell bar-coding for antibody discoveryABVITRO LLC·Filed 2014·Granted Nov 6, 2018·8 cites·23 claims
- 0589US10590483B2High-throughput nucleotide library sequencingABVITRO LLC·Filed 2015·Granted Mar 17, 2020·7 cites·39 claims
- 0682US11061030B2Affinity-oligonucleotide conjugates and uses thereofABVITRO LLC·Filed 2019·Granted Jul 13, 2021·1 cites·12 claims
- 0778US12129462B2Single cell bar-coding for antibody discoveryABVITRO LLC·Filed 2021·Granted Oct 29, 2024·0 cites·20 claims
- 0876US11118176B2Single cell bar-coding for antibody discoveryABVITRO LLC·Filed 2019·Granted Sep 14, 2021·0 cites·18 claims
- 0974US2022065856A1Affinity-oligonucleotide conjugates and uses thereofABVITRO LLC·Filed 2021·Application pending·0 cites
- 1073US2024076732A1High-throughput nucleotide library sequencingABVITRO LLC·Filed 2022·Application pending·0 cites
- 1165US2021293812A1High throughput process for t cell receptor target identification of natively-paired t cell receptor sequencesABVITRO LLC·Filed 2021·Application pending·0 cites
- 1264US11572403B2Broadly neutralizing anti-HIV-1 antibodies that bind to an N-glycan epitope on the envelopeABVITRO LLC·Filed 2020·Granted Feb 7, 2023·0 cites·23 claims
- 1363US11156611B2Single cell characterization using affinity-oligonucleotide conjugates and vessel barcoded polynucleotidesABVITRO LLC·Filed 2016·Granted Oct 26, 2021·0 cites·23 claims
- 1461US2020239955A1High-throughput nucleotide library sequencingABVITRO LLC·Filed 2020·Application pending·0 cites
- 1559US10928392B2High throughput process for T cell receptor target identification of natively-paired T cell receptor sequencesABVITRO LLC·Filed 2016·Granted Feb 23, 2021·0 cites·36 claims
- 1659US2025066774A1Engineered Guide RNAs and PolynucleotidesSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1759US2025009904A1RNA-Editing Compositions and Methods of UseSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1858US2025026795A1Functional aav capsids for intravitreal administrationSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1957US2025059538A1COMPOSITIONS AND METHODS OF tRNA SILENCINGSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2057US2025205363A1Functional aav capsids for systemic administrationSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2157US2021079454A1Methods of Sequencing, Determining, Pairing, and Validating Therapeutic Agents and Disease Specific AntigensABVITRO LLC·Filed 2020·Application pending·0 cites
- 2256US2025129127A1Systems for Amplification of AAV Rep and Cap ProteinsSHAPE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2355US2025356949A1Machine-learning based design of engineered guide systems for adenosine deaminase acting on rna editingSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2454US11142565B2Broadly neutralizing anti-HIV-1 antibodies that bind to an N-glycan epitope on the envelopeABVITRO LLC·Filed 2016·Granted Oct 12, 2021·0 cites·24 claims
- 2554US2025084408A1Engineered rnasSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2653US10982258B2Methods of sequencing, determining, pairing, and validating therapeutic agents and disease specific antigensABVITRO LLC·Filed 2016·Granted Apr 20, 2021·0 cites·37 claims
- 2752US2024271139A1Engineered Guide RNAs and PolynucleotidesSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2852US2024279656A1Engineered Guide RNAs and PolynucleotidesSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2952US2025011775A1Engineered Guide RNAs and PolynucleotidesBRIGGS ADRIAN·Filed 2022·Application pending·0 cites
- 3051US2021230671A1Methods for assessing integrated nucleic acidsJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3150US2023399635A1RNA-Editing Compositions and Methods of UseSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3249US2024102083A1High throughput rna-editing screening methodsSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3346US2025014676A1Generative sequence screening with conditional gans, diffusion models, and denoising diffusion conditional gansSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3446US2023193279A1Compositions and Methods for Modifying Target RNAsBRIGGS BRIAN·Filed 2021·Application pending·0 cites
- 3545US2023190798A1Cd19-directed chimeric antigen receptor t cell compositions and methods and uses thereofJUNO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3645US2023087953A1Bcma-directed chimeric antigen receptor t cell compositions and methods and uses thereofJUNO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3743US12049667B2High-throughput polynucleotide library sequencing and transcriptome analysisABVITRO LLC·Filed 2018·Granted Jul 30, 2024·0 cites·33 claims
- 3842US2018274021A1Single amplicon activated exclusion pcrABVITRO LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adrian Wrangham Briggs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →